Written by Holly Alyssa MacCormick In 2023, the California Institute for Regenerative Medicine (CIRM) funded a clinical trial led by Stanford researcher Crystal Mackall, MD, to investigate a possible therapy for rare brain and spinal tumors that arise from a specific genetic mutation, known as H3K27M. These cancers are devastating. Each year, about 1,000 people … Continue reading Closer to Cures: Stanford researcher Crystal Mackall discusses progress on clinical trials for rare cancers of the brain and spine with no known cure.
Closer to Cures
Closer to Cures: Cory R. Nicholas, CEO and co-founder of Neurona Therapeutics, discusses progress in clinical trials for patients with epilepsy that does not respond to drugs.
Written by Holly Alyssa MacCormick Cory R. Nicholas presenting at the January 29 ICOC board meeting Roughly 3 million adults living in the United States have epilepsy, and about 400,000 of these people live in California, according to the CDC. Of these people, about one-third to half continue to have seizures that do not respond to medications on the market. It’s those patients who don’t respond to medications that Neurona Therapeutics is hoping … Continue reading Closer to Cures: Cory R. Nicholas, CEO and co-founder of Neurona Therapeutics, discusses progress in clinical trials for patients with epilepsy that does not respond to drugs.
CIRM board supports a rare disease funding plan, administrative changes
Written by Holly Alyssa MacCormick South San Francisco, CA, January 30, 2026 – As many as 1 in 10 people in the U.S. has a rare disease, many of which have no known cure. A new program by the California Institute for Regenerative Medicine (CIRM) could change this by funding novel ways to develop multiple … Continue reading CIRM board supports a rare disease funding plan, administrative changes
The Stem Cellar 